Advertisements



Pharma, Biotech Bull ETFs Leading the Charge

This article was originally published on ETFTrends.com......»»

Category: topSource: foxnewsJul 12th, 2018

Walmart leading the retail charge against Amazon?

Amplify ETFS CEO Christian Magoon on the outlook for Walmart and JCPenney......»»

Category: topSource: moneycentralAug 16th, 2018

Sarepta Pharma Pushes Two Biotech ETFs to New Highs

The encouraging early trial results for a gene therapy for Duchenne muscular dyst.....»»

Category: smallbizSource: nytJun 20th, 2018

Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain

Deciphera Pharmaceuticals Inc (NASDAQ: DCPH) lost a sell-side bull Tuesday, with a B. Riley FBR analyst praising the company's pipeline but concluding the biotech's positives are priced into the stock. Late.....»»

Category: blogSource: benzingaJun 19th, 2018

Pharma & Biotech ETFs Soar on Trump"s Drug Plan

Zacks.....»»

Category: topSource: redinewsMay 14th, 2018

Pharma & Biotech ETFs Soar on Trump"s Drug Plan

Trump's drug plan went in favor of pharma and biotech companies, which caused .....»»

Category: smallbizSource: nytMay 14th, 2018

Pot purveyor lights the way for a new category of weed marketing

Cannabis retailer MedMen has been leading the charge to bring marijuana into the mainstream—a market estimated to hit $75 billion by 2030, says investment firm Cowen & Co. When recreational... To view the full story, click the title link......»»

Category: blogSource: crainsnewyorkDec 6th, 2018

The Decade-Long US Bull Market Will Come To An End Soon: Institutional Survey

Where will the world’s most sophisticated investors make their bets in 2019? Natixis Investment Managers, a leading global asset manager, today released its annual institutio.....»»

Category: blogSource: valuewalkDec 5th, 2018

5 ETFs Leading the Current Market Rally

Zacks.....»»

Category: topSource: redinewsDec 4th, 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to f.....»»

Category: blogSource: benzingaDec 2nd, 2018

The Week Ahead In Biotech: ASH Presentations Pick Up Pace, PDUFA Dates, Clinical Trials And IPOs

Large-cap pharma stocks are seeing some upward momentum and are on track to finish the year with handsome gains. As the year draws to a close, it remains to be see.....»»

Category: personnelSource: nytDec 2nd, 2018

The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stock.....»»

Category: earningsSource: benzingaNov 28th, 2018

The Daily Biotech Pulse: IntelliPharmaCeutics Generic Antidepressant Gets FDA Nod, GW Pharma Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours. None of the biotech stocks hit 52-week highs Tuesday. Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 27) read more.....»»

Category: blogSource: benzingaNov 28th, 2018

A Perspective On The Recent Meltdown In FAANG Stocks

Tech stocks, which led the rally for much of the current stock market bull run, are also leading the market sell-off that's occurred since the start of October.  read more.....»»

Category: blogSource: benzingaNov 21st, 2018

Tech giants that lifted stock market to historic highs now leading the way down

The decade-long bull market that emerged from t.....»»

Category: topSource: chicagotribuneNov 20th, 2018

7 Biotech ETFs to Consider for 2019

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biotech ETFs lagged in 2018, but that doesn't mean there aren't healthcare funds to consider for 2019. The post 7 Biotech ETFs to Consider for 2019 appeared first on InvestorPlace......»»

Category: topSource: investorplaceNov 20th, 2018

Biotech Analysis Central Pharma News: Pfizer"s Setback, Genfit"s Advance, Sage"s Postponement

Biotech Analysis Central Pharma News: Pfizer"s Setback, Genfit"s Advance, Sage"s Postponement.....»»

Category: topSource: seekingalphaNov 20th, 2018

Mid-Day Market Update: Crude Oil Down 5.5%; Bioblast Pharma Shares Spike Higher

Midway through trading Tuesday, the Dow traded down 1.38 percent to 24,673.10 while the NASDAQ declined 0.69 percent to 6,980.19. The S&P also fell, dropping 0.96 percent to 2,664.83. Leading and Lagging Sectors read more.....»»

Category: blogSource: benzingaNov 20th, 2018

Biotech Analysis Central Pharma News: AstraZeneca"s Setback, AbbVie"s Success, Arena"s Cash Influx

Biotech Analysis Central Pharma News: AstraZeneca"s Setback, AbbVie"s Success, Arena"s Cash Influx.....»»

Category: topSource: seekingalphaNov 19th, 2018

A Look at Mortgage REIT ETFs Post Q3 Earnings

Earnings beat by two leading mortage REITs brings these two ETFs in focus. Flattening of the yield curve has acted as a headwind for mortgage REITs (mREITs) lat.....»»

Category: worldSource: nytNov 15th, 2018

Samsung BioLogics" listing under review after regulator says it breached accounting rules

South Korea's top financial regulator said Samsung BioLogics Co Ltd had intentionally breached accounting rules ahead of its 2016 listing, leading to a suspension in trading of the biotech firm's shares and a review of its listing status......»»

Category: topSource: reutersNov 14th, 2018